Takeda Pharmaceutical Company Limited (TAK) has a market capitalization of $56.39B and trades at $17.85. The 52-week range is 12.99-18.9.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.5, Earnings Per Share (EPS) of $34.17, annual revenue of $4.58T.
The stock has a beta of 0.13, a last dividend of $0.3214, operates in the Healthcare sector.
